Dyslipidemia and nephrotic syndrome: recent advances.

Dyslipidemia and nephrotic syndrome: recent advances.

Item
http://www.wikidata.org/entity/Q36097028
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineTreatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.Serum lipoprotein changes in dogs with renal disease.Statin improves flow-mediated vasodilation in chronic kidney diseases.Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.
P2860

Dyslipidemia and nephrotic syndrome: recent advances.

Item
http://www.wikidata.org/entity/Q36097028
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Dyslipidemia and nephrotic syndrome: recent advances.
@ast
Dyslipidemia and nephrotic syndrome: recent advances.
@en
type
label
Dyslipidemia and nephrotic syndrome: recent advances.
@ast
Dyslipidemia and nephrotic syndrome: recent advances.
@en
prefLabel
Dyslipidemia and nephrotic syndrome: recent advances.
@ast
Dyslipidemia and nephrotic syndrome: recent advances.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Dyslipidemia and nephrotic syndrome: recent advances.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921